Company: ARMP
Filing Date: 2025-05-01
Form Type: 8-K
Source: 0001104659-25-043017
Chunk: 0

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-05-01
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01      Other Events.  

On May 1, 2025, the Company issued a press release announcing
that it had received $4.65 million of additional non-dilutive award funding from the U. S. Department of Defense for the development of
bacteriophage therapy to treat Staphylococcus aureusbacteremia infections. The full text of the press release issued
in connection with this announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein
by reference.